Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
PIP [AMEX]
PharmAthene, Inc.
Index- P/E- EPS (ttm)-0.10 Insider Own2.66% Shs Outstand49.46M Perf Week-8.47%
Market Cap80.13M Forward P/E- EPS next Y-0.33 Insider Trans- Shs Float49.29M Perf Month1.25%
Income-4.92M PEG- EPS next Q-0.06 Inst Own33.59% Short Float8.45% Perf Quarter17.39%
Sales25.18M P/S3.18 EPS this Y-26.91% Inst Trans3.62% Short Ratio10.50 Perf Half Y58.82%
Book/sh0.21 P/B7.71 EPS next Y-1000.00% ROA-21.61% Target Price7.25 Perf Year22.73%
Cash/sh0.26 P/C6.31 EPS next 5Y- ROE-35.75% 52W Range0.98 - 2.05 Perf YTD44.64%
Dividend- P/FCF- EPS past 5Y0.00% ROI-29.43% 52W High-22.44% Beta1.64
Dividend %- Quick Ratio- Sales past 5Y11.45% Gross Margin- 52W Low62.23% ATR0.07
Employees57 Current Ratio2.64 Sales Q/Q-3.62% Oper. Margin-24.89% RSI (14)35.43 Volatility5.25% 4.05%
OptionableYes Debt/Eq0.32 EPS Q/Q-268.98% Profit Margin-19.54% Rel Volume1.49 Prev Close1.62
ShortableYes LT Debt/Eq0.15 EarningsMay 08 AMC Payout- Avg Volume396.69K Price1.59
Recom2.00 SMA20-5.56% SMA50-4.29% SMA20018.91% Volume56,870 Change-1.86%
06-Mar-13Initiated Aegis Capital Buy $6
04-Jun-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $7
28-Nov-11Downgrade WBB Securities Strong Buy → Hold $2
04-Jan-11Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $2.50
29-Nov-10Reiterated WBB Securities Strong Buy $6 → $8.50
18-Oct-10Upgrade WBB Securities Buy → Strong Buy $3.50 → $6
23-Jul-10Upgrade WBB Securities Speculative Buy → Buy $3.50
03-Feb-09Initiated Rodman & Renshaw Mkt Outperform $6
20-May-13 04:14PM  July Options Now Available For PharmAthene (PIP) at TheStreet
14-May-13 01:04PM  PHARMATHENE, INC Financials EDGAR Online Financials
12-May-13 08:13AM  Biodefense: Live By Government Contracts, Die By Government Contracts at Seeking Alpha
08-May-13 08:10PM  PharmAthene Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:16PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:00PM  PharmAthene Reports First Quarter 2013 Financial And Operational Results PR Newswire
09:14AM  PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:37AM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
07:07AM  Q1 2013 PharmAthene, Inc. Earnings Release - After Market Close CCBN
06-May-13 03:55PM  PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013 PR Newswire
24-Apr-13 12:00PM  Trucks Oust Buffaloes as Aquino $6.5 Billion Adds Roads: Freight at Bloomberg
17-Apr-13 10:16AM  PharmAthene says Army completed recombinant bioscavenger testing at theflyonthewall.com
10:11AM  InPlay: PharmAthene reports new data show PharmAthene's Recombinant Bioscavenger binds to a broad spectrum of chemical nerve agents Briefing.com
10:11AM  New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents PR Newswire
25-Mar-13 09:50AM  PHARMATHENE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a EDGAR Online
19-Mar-13 01:04PM  PHARMATHENE, INC Financials EDGAR Online Financials
15-Mar-13 05:00AM  PharmAthene Inc. Stock Downgraded (PIP) at TheStreet -5.71%
14-Mar-13 08:03PM  New Star Analyst Rankings for PharmAthene, Inc Common Stock StarMine
06:02AM  PHARMATHENE, INC Files SEC form 10-K, Annual Report EDGAR Online
13-Mar-13 06:40PM  PharmAthene Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha -9.60%
04:30PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:09PM  PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  PharmAthene Reports Year-End 2012 Financial And Operational Results PR Newswire
07:07AM  Q4 2012 PharmAthene, Inc. Earnings Release - After Market Close CCBN
12-Mar-13 09:27AM  PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013 PR Newswire +10.00%
06-Mar-13 03:00PM  UPS Gets an Outperform and 4 Analyst Notes to Know at Wall St. Cheat Sheet +6.98%
12:39AM  Coverage initiated on PharmAthene by Aegis Capital Briefing.com
11-Feb-13 01:58PM  5 Medical Stock Losers From Last Week With High Short Ratios at Seeking Alpha
17-Jan-13 01:01PM  5 Under-$10 Plays Primed to Pop at TheStreet
12:47PM  5 Under-$10 Plays Primed to Pop at TheStreet
09:30AM  PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013 PR Newswire
14-Jan-13 10:19AM  InPlay from Briefing.com Briefing.com -5.26%
10:08AM  InPlay: PharmAthene secures exclusive license to PER.C6 cell line for commercial production of recombinant bioscavenger Briefing.com
10:07AM  PharmAthene Secures Exclusive License To PER.C6® Cell Line For Commercial Production Of Recombinant Bioscavenger PR Newswire
11-Jan-13 05:56PM  Noble Financial January 22-23 Equity Conference Attracts More Than 100 Public Companies Marketwire +17.70%
11:58AM  Good Chance For PharmAthene To Jump On Lucrative SIGA Litigation at Seeking Alpha
10-Jan-13 04:57PM  4 Healthcare Stock Stories Prescribed for Investors at Wall St. Cheat Sheet
04:41PM  InPlay from Briefing.com Briefing.com
04:17PM  InPlay from Briefing.com Briefing.com
03:43PM  InPlay from Briefing.com Briefing.com
03:03PM  InPlay from Briefing.com Briefing.com
02:41PM  InPlay: PharmAthene announces Delaware Supreme Court hears oral arguments in its litigation with SIGA Technologies Briefing.com
02:40PM  PharmAthene Announces Delaware Supreme Court Hears Oral Arguments In Its Litigation With SIGA Technologies PR Newswire
16-Nov-12 01:04PM  PHARMATHENE, INC Financials EDGAR Online Financials
12-Nov-12 04:08AM  PharmAthene Inc. Stock Upgraded (PIP) at TheStreet
07-Nov-12 09:36AM  New Star Analyst Rankings for PharmAthene, Inc Common Stock StarMine
06-Nov-12 06:20PM  PharmAthene Management Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:20PM  PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:17PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:00PM  PharmAthene Reports Third Quarter 2012 Financial Results PR Newswire
07:07AM  Q3 2012 PharmAthene, Inc. Earnings Release - After Market Close CCBN
05-Nov-12 10:30AM  PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012 PR Newswire
19-Oct-12 05:14PM  PHARMATHENE, INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online -5.41%
10-Sep-12 08:31AM  PHARMATHENE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
14-Aug-12 02:25PM  PharmAthene - All Is Not Lost Yet at Seeking Alpha
01:04PM  PHARMATHENE, INC Financials EDGAR Online Financials
10-Aug-12 09:16PM  Healthcare Biz Recap: Pfizer FAILS Trial, Mylans Generic WINS FDA Okay at Wall St. Cheat Sheet -13.01%
05:53PM  Healthcare Business Recap: Pfizer FAILS Trial, Mylans Generic WINS FDA Okay at Wall St. Cheat Sheet
03:13PM  Healthcare Review: PharmAthene & Codexis Slump On News, Amicus Rises Thomson Reuters ONE
02:25PM  Movers roundup: Roundy's, PharmAthene AP
09:01AM  InPlay: PharmAthene receives notification from FDA that its SparVax rPA anthrax vaccine program has been placed on clinical hold Briefing.com
09:00AM  PharmAthene Receives FDA Notification On SparVax PR Newswire
09-Aug-12 10:00AM  InPlay: PharmAthene: Department of Defense exercises options under contract for nerve agent medical countermeasure program Briefing.com +6.57%
10:00AM  Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program PR Newswire
08-Aug-12 09:39AM  New Star Analyst Rankings for PharmAthene, Inc Common Stock StarMine
07-Aug-12 04:38PM  PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:02PM  PharmAthene Reports Second Quarter 2012 Financial Results PR Newswire
17-Jul-12 04:06AM  Why Early Tuesday's Biotech Edge Is Bullish at Seeking Alpha
12-Jul-12 12:28PM  5 Stocks Under $10 Set to Soar at TheStreet
11-Jul-12 12:50PM  Biotech Dangers at Motley Fool
11:30AM  Biotech Dangers at Motley Fool
02-Jul-12 01:24PM  2 Promising Small-Cap Pharma Plays Trading Under $5/Share at Seeking Alpha
01-Jul-12 05:21AM  2 Pharma Plays Trading Under $2 For The Aggressive Investor at Seeking Alpha
28-Jun-12 04:07PM  PHARMATHENE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
18-Jun-12 06:52AM  USF adds new members to board of directors at bizjournals.com
14-Jun-12 11:17AM  InPlay: PharmAthene announces progress in development of its SparVax anthrax vaccine program: completes release of final drug product Briefing.com
11:15AM  PharmAthene Announces Further Progress In Development Of Its SparVax Anthrax Vaccine Program PR Newswire
12-Jun-12 05:33PM  Siga appeals PharmAthene smallpox drug ruling AP
07-Jun-12 05:09PM  7 Stocks Under $10 Streaking Higher at TheStreet +10.81%
04-Jun-12 02:15PM  Analysts Issue a Thumbs Up or Thumbs Down on These Stocks Today at Wall St. Cheat Sheet
10:56AM  Galena Biopharma, PharmAthene Gapping Up Monday at Fox Business
09:20AM  PharmAthene upgraded to Outperform from Market Perform at Rodman & Renshaw at theflyonthewall.com
02:13AM  PharmAthene upgraded by Rodman & Renshaw Briefing.com
01-Jun-12 06:12PM  Health Care Sector Wrap at Fox Business +27.87%
04:48PM  Healthcare Business Recap: Sanofis POSITIVE Results, PharmAthene Shares SPIKE at Wall St. Cheat Sheet
11:56AM  PharmAthene Pops 37% to Lead These BUZZING Stocks at Wall St. Cheat Sheet
11:26AM  PharmAthene climbs on smallpox drug ruling AP
07:08AM  PharmAthene says court issues final judgment in litigation with SIGA Technologies theflyonthewall.com
07:01AM  InPlay: PharmAthene: Delaware Chancery Court issues final order and judgment upholding its favorable ruling Briefing.com
07:00AM  Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling PR Newswire
17-May-12 01:05PM  PHARMATHENE, INC Financials EDGAR Online Financials
10-May-12 10:46AM  PHARMATHENE, INC Files SEC form 10-Q, Quarterly Report EDGAR Online
09-May-12 10:30AM  New Star Analyst Rankings for PharmAthene, Inc Common Stock StarMine
08-May-12 04:30PM  PharmAthene, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  PharmAthene on track to initiate Sparvax Phase 2 trial for later this year theflyonthewall.com
04:12PM  PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:02PM  PharmAthene Reports First Quarter 2012 Financial Results PR Newswire
07:07AM  Q1 2012 PharmAthene, Inc. Earnings Release - After Market Close CCBN
PharmAthene, Inc., a biodefense company, engages in the development and commercialization of medical countermeasures against biological and chemical threats in the United States. Its product candidates include SparVax, a recombinant protective antigen anthrax vaccine that has completed a Phase IIb clinical trial for post-exposure prophylaxis in conjunction with antibiotics and general use prophylaxis; Valortim, a human monoclonal antibody, which has completed a Phase I clinical trial for the prevention and treatment of anthrax infection; and rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides. The company primarily serves the United States Department of Defense, Chemical Biological Medical Systems, the National Institute of Allergy and Infectious Diseases, the Biomedical Advanced Research and Development Authority, and the National Institute of Health. It has a collaboration agreement with Bristol Myers Squibb, Inc. for the development of Valortim. The company was founded in 2001 and is headquartered in Annapolis, Maryland.